USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Global Point-of-care Testing Growth Opportunities
Molecular POCT Unlocking Growth Potential in the Distributed Diagnostic Data Ecosystem
15-Nov-2023
North America
Market Research
K973-01-00-00-00
HC_2023_319
$4,950.00
Special Price $3,712.50 save 25 %
This study provides an overview of the global point-of-care testing (POCT) industry, which refers to any routine or specialized lab pathology
testing conducted rapidly, on-site/near the site of the patient, where care or treatment is provided. COVID-19 radicalization is changing the global diagnostics landscape. Consolidation trends, structural shifts in healthcare settings, and the extension of POCT to sexually transmitted infections (STIs), antimicrobial resistance (AMR), routine testing, oncology, and newborn screening are shaping new frontiers. In the future, therapy areas such as oncology, stroke, and dementia will represent the POCT repertoire.
In developed economies, the proliferation of syndromic testing, multiplexing making inroads in immunoassay, evolution in nucleic acid
amplification technology (from PCR to Isothermal Amplification), the use of saliva specimens, and advancements in antimicrobial resistance
testing are increasing the market viability. Furthermore, AI/ML-enabled device software functions incorporating predetermined change control
plans under the diagnostic data program initiative offer accelerated market opportunities in the United States.
In developing economies, multiparametric platforms have emerged to respond to an escalating POC demand in emergency departments and
small-medium labs. In addition, a strong pull toward preventive health is laying the foundation to advance routine testing using emerging blood testing platforms.
A robust multiplex ecosystem tied with the converging potential of diagnostic data creating new revenue streams (e.g., connectivity and digital healthcare technology services) exemplifies the pivot from COVID-19 testing, adapting to changing clinical pathways and greater harmonization
of lab-based and non-lab-based diagnostic data for similar tests to build a more sustainable point-of-care ecosystem.
Author: Amartya Bose
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Point-of-care Testing (POCT) Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Scope of Analysis
Scope of Analysis (continued)
Segmentation—Test Type
Segmentation—Care Continuum
Key Competitors
Growth Metrics
Growth Drivers
Growth Drivers (continued)
Growth Restraints
Growth Restraints (continued)
Forecast Assumptions
Revenue Forecast
Revenue Forecast by Test Type
Revenue Forecast by Region
Revenue Forecast by Care Continuum
Forecast Analysis
Forecast Analysis (continued)
Forecast Analysis (continued)
Forecast Analysis (continued)
Forecast Analysis (continued)
Forecast Analysis (continued)
Pricing Trends and Forecast Analysis
Competitive Environment
POCT Across Different Therapy Areas
Revenue Share
Revenue Share Analysis
Revenue Share Analysis (continued)
Revenue Share Analysis (continued)
Revenue Share Analysis (continued)
Competitor Matrix—Therapy Areas
Competitor Matrix—Technology Mapping
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Revenue Forecast by Immunochemistry POCT
Forecast Analysis
Forecast Analysis (continued)
Forecast Analysis (continued)
Forecast Analysis (continued)
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Revenue Forecast by Molecular POCT Therapy Areas
Forecast Analysis
Forecast Analysis (continued)
Forecast Analysis (continued)
Forecast Analysis (continued)
Growth Opportunity 1: Molecular POCT
Growth Opportunity 1: Molecular POCT (continued)
Growth Opportunity 2: Multiplexing
Growth Opportunity 2: Multiplexing (continued)
Growth Opportunity 3: STI POCT
Growth Opportunity 3: STI POCT (continued)
Growth Opportunity 4: AMR POCT
Growth Opportunity 4: AMR POCT (continued)
Growth Opportunity 5: Routine POCT
Growth Opportunity 5: Routine POCT (continued)
Growth Opportunity 6: Smartphone POCT
Growth Opportunity 6: Smartphone POCT (continued)
Future of POCT in Care Continuum
Your Next Steps
Why Frost, Why Now?
List of Exhibits
Legal Disclaimer
List of Figures
- POCT Industry: Growth Metrics, Global, 2023
- POCT Industry: Growth Drivers, Global, 2024–2028
- POCT Industry: Growth Restraints, Global, 2024–2028
- POCT Industry: Revenue Forecast, Global, 2023–2028
- POCT Industry: Revenue Forecast by Test Type, Global, 2023–2028
- POCT Industry: Revenue Forecast by Region, 2023–2028
- POCT Industry: Revenue Forecast by Care Continuum, Global, 2023–2028
- POCT Industry: Revenue Share of Top Participants, Global, 2023
- POCT Industry: Competitor Matrix for Therapy Area Portfolio Assessment, Global, 2023
- Immunochemistry POCT: Growth Metrics, Global, 2023
- Immunochemistry POCT: Revenue Forecast, Global, 2023–2028
- Immunochemistry POCT: Revenue Forecast by Region, 2023–2028
- Immunochemistry POCT Industry: Revenue Forecast by Therapy Areas, 2023–2028
- Molecular POCT: Growth Metrics, Global, 2023
- Molecular POCT: Revenue Forecast, Global, 2023–2028
- Molecular POCT: Revenue Forecast by Region, 2023–2028
- Molecular POCT Industry: Revenue Forecast by Therapy Areas, Global, 2023–2028
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
27 Aug 2026 | Global | Frost Radar
Frost Radar: AI-Powered Molecular Diagnostics, 2026
AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...
26 Aug 2026 | Global | Technology Research
Growth Opportunities and Advancements in Acute and Chronic Wound Care
A wound is any disruption in the normal structure and function of the skin or underlying tissues. It can result from physical injury, surgery, or underlying medical conditions. Wounds are broadly classified into two categories: acute wounds and chronic wounds. Acute wounds typically heal through the...
26 Aug 2026 | Global | Frost Radar
Frost Radar™: Healthcare Infrastructure Cybersecurity in the United States, 2026
Healthcare organizations are expanding their digital environments across cloud infrastructure, connected medical devices, applications, identities, operational technology, and distributed care settings, creating a broader and increasingly interconnected attack surface. Cybersecurity is, therefore, e...
25 Aug 2026 | Global | Technology Research
Breakthrough Innovations in Point-of-Care Diagnostics
This research analyzes how point-of-care (PoC) diagnostics is evolving from simple tests to decentralized, connected, and clinically actionable testing platforms across hospitals, outpatient settings, homes, and pharmacies.
The study assesses key technology shifts, including rapid molecular t...
25 Aug 2026 | Global | Technology Research
Innovations and Growth Opportunities in Digital Biomarkers
A digital biomarker refers to measurable data about physiological functions or behaviors collected through digital devices and technologies, such as wearables, implants, ingestible sensors, smartphones, and mobile applications.
These biomarkers provide continuous, real-time insights into an ...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| Author | Amartya Bose |
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | Point Of Care Molecular Diagnostics |
| Keyword 2 | Poc Testing Trends |
| Keyword 3 | Point-Of-Care Testing Insights |
| List of Charts and Figures | POCT Industry: Growth Metrics, Global, 2023~ POCT Industry: Growth Drivers, Global, 2024–2028~ POCT Industry: Growth Restraints, Global, 2024–2028~ POCT Industry: Revenue Forecast, Global, 2023–2028~ POCT Industry: Revenue Forecast by Test Type, Global, 2023–2028~ POCT Industry: Revenue Forecast by Region, 2023–2028~ POCT Industry: Revenue Forecast by Care Continuum, Global, 2023–2028~ POCT Industry: Revenue Share of Top Participants, Global, 2023~ POCT Industry: Competitor Matrix for Therapy Area Portfolio Assessment, Global, 2023~ Immunochemistry POCT: Growth Metrics, Global, 2023~ Immunochemistry POCT: Revenue Forecast, Global, 2023–2028~ Immunochemistry POCT: Revenue Forecast by Region, 2023–2028~ Immunochemistry POCT Industry: Revenue Forecast by Therapy Areas, 2023–2028~ Molecular POCT: Growth Metrics, Global, 2023~ Molecular POCT: Revenue Forecast, Global, 2023–2028~ Molecular POCT: Revenue Forecast by Region, 2023–2028~ Molecular POCT Industry: Revenue Forecast by Therapy Areas, Global, 2023–2028~ |
| Podcast | No |
| WIP Number | K973-01-00-00-00 |